{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Belova L"],"funding":["Ministry of Science and Higher Education of the Russian Federation"],"pagination":["879"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12024971"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(4)"],"pubmed_abstract":["<b>Background:</b> Organoids are a valuable model for studying hereditary diseases such as cystic fibrosis (CF). Recombinant adenoviral (rAdV) and adeno-associated viral (rAAV) vectors are promising tools for CF gene therapy and genome editing. <b>Objective:</b> This study aims to determine the most efficient viral vector (rAdV5, rAAV serotypes 5, 6 and 9) and transduction protocol for delivering transgenes to lung organoids (LOs), providing a foundation for future CF gene therapy development. <b>Methods:</b> Three transduction protocols were used taking into account the specificities of LOs' cultivation in specific matrices, both with and without organoid extraction from the matrix. This work was carried out on organoids from a healthy donor (LOs-WT) and on a patient with cystic fibrosis "],"journal":["Biomedicines"],"pubmed_title":["Lung Organoids from hiPSCs Can Be Efficiently Transduced by Recombinant Adeno-Associated Viral and Adenoviral Vectors."],"pmcid":["PMC12024971"],"funding_grant_id":["none"],"pubmed_authors":["Zubkova O","Erofeeva A","Lavrov A","Smirnikhina S","Kochergin-Nikitsky K","Popova O","Ozharovskaia T","Belova L","Salikhova D","Efremova A","Demchenko A"],"additional_accession":[]},"is_claimable":false,"name":"Lung Organoids from hiPSCs Can Be Efficiently Transduced by Recombinant Adeno-Associated Viral and Adenoviral Vectors.","description":"<b>Background:</b> Organoids are a valuable model for studying hereditary diseases such as cystic fibrosis (CF). Recombinant adenoviral (rAdV) and adeno-associated viral (rAAV) vectors are promising tools for CF gene therapy and genome editing. <b>Objective:</b> This study aims to determine the most efficient viral vector (rAdV5, rAAV serotypes 5, 6 and 9) and transduction protocol for delivering transgenes to lung organoids (LOs), providing a foundation for future CF gene therapy development. <b>Methods:</b> Three transduction protocols were used taking into account the specificities of LOs' cultivation in specific matrices, both with and without organoid extraction from the matrix. This work was carried out on organoids from a healthy donor (LOs-WT) and on a patient with cystic fibrosis ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Apr","modification":"2026-04-08T15:50:15.768Z","creation":"2025-06-27T03:05:24.758Z"},"accession":"S-EPMC12024971","cross_references":{"pubmed":["40299508"],"doi":["10.3390/biomedicines13040879"]}}